Alchemab Therapeutics


Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of hard-to-treat disease in a unique and transformative approach to drug discovery and development.

Industries

Employees

11-50

Links


Org chart

Jane Osbourn
Chief Scientific Officer
Paul Varley
SVP, Development
Ralph Minter
SVP, Research
Alexander Hewitson
VP of Operations
Jake Galson
VP of Technology
Jenny Howell
Head of Project & Portfolio Management
Donna Finch
Head of Translational & Clinical Sciences
Becky Eretta
Head Of Human Resources
Maureen West
Senior Scientist
Olivia Snudden
Associate Project Manager
Ruth Jones
Senior Scientist
Sophie Sanford
Senior Scientist

Board & advisors

Andrew Levin
Director
John Hamer
Director
Kevin Lee
Director


Offices